SPEN and ovarian cancer: Overexpression of SPEN-Polyvalent transcriptional co-repressor have been suggested as an enhancer of the Wnt pathway, which has been also reported in colon and ovarian cancers.[28, 29, 31, 32] Currently, no targeted therapies are available.